SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-077228
Filing Date
2022-03-16
Accepted
2022-03-16 16:06:29
Documents
85
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d159262d10k.htm   iXBRL 10-K 2245078
2 EX-4.5 d159262dex45.htm EX-4.5 43183
3 EX-23.1 d159262dex231.htm EX-23.1 2224
4 EX-31.1 d159262dex311.htm EX-31.1 10450
5 EX-31.2 d159262dex312.htm EX-31.2 10507
6 EX-32.1 d159262dex321.htm EX-32.1 3812
7 EX-32.2 d159262dex322.htm EX-32.2 3797
13 GRAPHIC g159262dsp_53.jpg GRAPHIC 70655
  Complete submission text file 0001193125-22-077228.txt   8245794

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cprx-20211231.xsd EX-101.SCH 54291
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20211231_cal.xml EX-101.CAL 55989
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20211231_def.xml EX-101.DEF 195522
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20211231_lab.xml EX-101.LAB 448207
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20211231_pre.xml EX-101.PRE 352608
79 EXTRACTED XBRL INSTANCE DOCUMENT d159262d10k_htm.xml XML 1258730
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33057 | Film No.: 22744919
SIC: 2834 Pharmaceutical Preparations